Aging/Research reports/2026-09-29
Disposal or redistribution?
Today's result
Cumulative claim AG-C03 is constrained: the proposed link between TIMP2, cargo degradation and neuronal function additionally requires a separate assessment of export. For aggregation-capable cargo, the ability to initiate further aggregation after release must also be assessed. This is our model critique, not an observation from TIMP2 treatment.
Source delta: one primary study added to the register, two existing studies selectively re-examined. The register now contains 23 DOI-unique studies. “New” means newly included; the additional paper was published on 6 April 2026. No experiments, raw-data reanalyses or numerical effect estimates were performed by this project.
Keep four levels separate
| Category | Today's assessment | Evidence and project status |
|---|---|---|
| Established methodological knowledge | A stock does not measure an individual flow rate. Lysosomal location alone does not demonstrate complete degradation. | Balance argument, not clinical efficacy. ⚪ Level 1. |
| Promising indications | TIMP2 remains a mechanistically interesting candidate, but mediation through selective degradation is unconfirmed. | Preclinical indications; confidence in the complete target chain is low. 🔵 AG-T01 / Level 2. |
| External experimental results | Three measurement approaches provide origin tracing, processing signals and an export counterexample. They address different questions. | Animal/cell models, not treatment outcomes in humans. ⚪ Level 1 for published findings. |
| Project hypothesis | Benefit through cargo degradation requires preserved synapses, improved function and exclusion of harmful redistribution together. | Unconfirmed synthesis; novelty and independent confirmation have not been established. 🔵 Level 2. |
What the measurements support
- AG-R01 · Hemmer/Philippi et al., 12 Aug 2026: The pHrodo-myelin assay tracks uptake into acidic compartments. Signal loss is assessed after loading and washout; this does not specifically separate degradation from export. Lysosomal VGLUT1 is a stock measurement. Evidence: moderate for the preclinical processes tested, insufficient for the complete AG-T01 chain. Primary full text and methods
- AG-S10 = AG-R02 · Guldner et al., 21 Jan 2026: Neuron-specific labeling and proteomics support neuronal protein transfer to microglia. Lysosomal assignment is not a microglial degradation flux. Evidence: moderate for origin/stock in the model examined. Indexed publisher sections on Figure 5 and methods were checked today; direct full-text retrieval failed. Primary study
- AG-D01 · Karabova et al., 6 Apr 2026: Human iPSC-derived microglia-like cells released fibrillar tau retaining aggregation-seeding activity. Functional assays included engineered reporters and assisted delivery. Evidence: moderate for a cellular export counterexample, not a physiological transfer rate or a TIMP2 effect. Primary study, Figure 7 and methods 2.24–2.25
Project inference: an identifiability limit
For intact labeled cargo C, the previous model gives:
dC/dt = U − D − E − L
U is uptake, D degradation, E export and L cargo lost as cells leave the tracked population. All flows share units, such as cargo amount per time. Even if C and U were known, only D + E + L would initially be determined.
Setting D* = D + h and E* = E − h preserves the same C trajectory while the flows remain nonnegative. This is a symbolic non-uniqueness check, not a fit to measured data. Even in the simplified measurement model F = αC, the response α can vary, for example through pH. Real signals can additionally originate from labeled fragments; specific measurement of intact cargo requires validation. Washing limits external input but does not automatically resolve this ambiguity.
Consequence for the next source assessment: Seek a dataset measuring intracellular intact cargo, breakdown products and exported cargo alongside cell number and measurement response. For aggregation-capable cargo, mass and seeding activity require separate assessment. Mass-normalized activity alone is not the total exported activity; fractions must not be double-counted or combined linearly without calibration.
Contradictions, independence and limitations
The textual tension between synaptic cargo and myelin in AG-R01 remains open. Methods were checked in the primary full text; Supplementary Figure 5u,v could not be visually inspected today. Substrate differences, measurement context and a textual error remain competing explanations. No silent reconciliation.
The tau paper supplies another cellular context and a countermechanism. It neither replicates the TIMP2 study nor models naturally aged human brains. Multiple assays in one study do not constitute multiple independent confirmations. A complete assessment of shared data and methods remains pending. Targeted searches found no correction/retraction notice for the selected DOIs; this does not replace a comprehensive registry audit.
Decision and next executable step
AG-C03 and approach AG-A03 retain their status but gain the export constraint. No levels 3–5. Today's review produces no new efficacy claim for the axolotl branch; injury regeneration remains distinct from aging.
Next, assess available cargo and medium measurements for balance completeness, reuptake and retained activity. Reproducible recalculation becomes useful only if suitable data exist. Later external confirmation would need to test benefit and possible redistribution together; this project conducts no such experiments.
These updates provide reading material for existing professor assignments AG-P17–20. No duplicate supplement today: evidence dependency, cargo balance and competing models are already covered there.
Sources and search
- AG-R01: DOI 10.1038/s41467-026-74906-z · published 12 Aug 2026 · primary full text/methods checked today; supplementary access limited.
- AG-S10 / AG-R02: DOI 10.1038/s41586-025-09987-9 · published 21 Jan 2026, issue date 26 Feb 2026 · indexed primary sections today; no new direct full-text access.
- AG-D01: DOI 10.1002/alz.71337 · online 6 Apr 2026 · publisher full text, Figure 7 legend, relevant methods and bibliographic metadata checked; no comprehensive raw-data/supplement audit.
Retrieval date for today's checks: 29 September 2026. Targeted search families: TIMP2/myelin/Supplement 5; neuronal labeling/protein transfer/degradation; microglia/tau/export/seeding; selected DOI plus correction/retraction. Neither a systematic review nor complete coverage of new September publications. No personal treatment plans or self-medication advice.
Continue exploring
